Details
Stereochemistry | ACHIRAL |
Molecular Formula | Ra |
Molecular Weight | 223.0185 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 2 |
SHOW SMILES / InChI
SMILES
[223Ra++]
InChI
InChIKey=PZDJSXWIQXZUBJ-OIOBTWANSA-N
InChI=1S/Ra/q+2/i1-3
DescriptionCurator's Comment: description was created based on several sources, including
http://www.ncbi.nlm.nih.gov/pubmed/?term=23653243; http://www.ncbi.nlm.nih.gov/pubmed/?term=23977665
Curator's Comment: description was created based on several sources, including
http://www.ncbi.nlm.nih.gov/pubmed/?term=23653243; http://www.ncbi.nlm.nih.gov/pubmed/?term=23977665
Radium Ra 223 dichloride is a radiotherapeutic drug that is approved for the treatment of male patients with symptoms of advanced prostate cancer with bone metastases. Ra 223 mimics calcium and forms complexes with the bone mineral hydroxyapatite at areas of increased bone turnover. The radioactive alpha particles emitted by radium Ra 223 helps in killing cancer cells in the bone by damaging their DNA. Radium Ra 223 causes minimal damage to the nearby healthy cells.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | XOFIGO Approved UseXofigo is an alpha particle-emitting radioactive thera peutic agent indicated for the treatment of patients with castration-resistant prostate cancer, symptoma tic bone metastases and no known visceral metastatic disease Launch Date2013 |
Sample Use Guides
The dose regimen is 50 kBq (1.35 microcurie) per kg body weight, given at 4 week intervals for 6 injections.
Route of Administration:
Intravenous
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000187053
Created by
admin on Sat Dec 16 11:05:45 GMT 2023 , Edited by admin on Sat Dec 16 11:05:45 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB14571
Created by
admin on Sat Dec 16 11:05:45 GMT 2023 , Edited by admin on Sat Dec 16 11:05:45 GMT 2023
|
PRIMARY | |||
|
9H414A99MD
Created by
admin on Sat Dec 16 11:05:45 GMT 2023 , Edited by admin on Sat Dec 16 11:05:45 GMT 2023
|
PRIMARY | |||
|
1745075
Created by
admin on Sat Dec 16 11:05:45 GMT 2023 , Edited by admin on Sat Dec 16 11:05:45 GMT 2023
|
PRIMARY | |||
|
9H414A99MD
Created by
admin on Sat Dec 16 11:05:45 GMT 2023 , Edited by admin on Sat Dec 16 11:05:45 GMT 2023
|
PRIMARY | |||
|
N0000187052
Created by
admin on Sat Dec 16 11:05:45 GMT 2023 , Edited by admin on Sat Dec 16 11:05:45 GMT 2023
|
PRIMARY | alpha-Particle Emitting Activity [MoA] |
ACTIVE MOIETY